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Monoclonal antibody against kanamycin was prepared,
and competitive direct ELISA and immunochromatographic
assay were developed using the antibody to detect kanamycin
in animal plasma and milk. The monoclonal antibody
produced was identified to be IgG1, which has a kappa
light chain. No cross-reactivity of the antibody was
detected with other aminoglycosides, indicating that the
monoclonal antibody was highly specific for kanamycin.
Based on competitive direct ELISA, the detection limits of
kanamycin were determined to be 1.1 ng/ml in PBS, 1.4
ng/ml in plasma, and 1.0 ng/ml in milk. The concentration
of intramuscularly injected kanamycin was successfully
monitored in rabbit plasma with competitive direct ELISA.
Based on the colloidal gold-based immunochromatographic
assay, the detection limits of kanamycin were estimated to
be about 6-8 ng/ml in PBS, plasma, and milk. The
immunochromatographic assay would be suitable for
rapid and simple screening of kanamycin residues in
veterinary medicine. Screened positives can be confirmed
using a more sensitive laboratory method such as competitive
direct ELISA. Therefore, the assays developed in this
study could be used to complement each other as well as
other laboratory findings. Moreover, instead of slaughtering
the animals to obtain test samples, these methods could be
applied to determine kanamycin concentration in the
plasma of live animals.
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Introduction
Kanamycin, an aminoglycoside antibiotic produced by
Streptomyces kanamyceticus, is widely used in veterinary
medicine to treat mastitis, bacillary diarrhea, and pneumonia
[1]. It is classified as a broad-spectrum antibiotic due to its
growth inhibition of Escherichia coli, Pseudomonas aeruginosa,
Klebsiella spp., and Proteus  spp. [16], and is known to
perturb protein synthesis in Gram-negative bacteria by
binding to the 30 S subunit of ribosomal RNA, which causes
misreading of the genetic code and inhibits translation
[6,15]. Kanamycin is a mixture of 3 isomers: kanamycin A,
kanamycin B, and kanamycin C. Since the kanamycin
components differ markedly in their toxicity, commercial
mixtures are required to contain at least 75% kanamycin A
and no more than 5% kanamycin B [17].
Despite its impressive clinical effectiveness, kanamycin is
potentially ototoxic and nephrotoxic in humans and animals
[5]; thus monitoring of the level of its residues in food is
essential for the maintenance of public health. For consumer
protection, the European Agency for the Evaluation of
Medical Products (EMEA) established maximum residue
limits (MRL) for edible tissues, and milk: 100 µg/kg for
meat, 150 µg/kg for milk, and 100 µg/kg for porcine fat [4].
The MRL of kanamycin in Japan has been set at 250 mg/kg
for animal tissue [20]. Therefore, simple and reliable analytical
methods are required to monitor kanamycin residue levels in
livestock. Various techniques have been developed for the
detection of kanamycin residues in milk, urine, blood, and
tissues including: microbioassay [13], gas chromatography
(GC) [9], high-performance liquid chromatography (HPLC)
[11], and enzyme-linked immunosorbent assay (ELISA)
[2,10,20]. ELISA has become the most popular method for
the detection of chemicals in foods due to its high sensitivity,
simplicity, and ability to screen large number of small-
volume samples.
In the veterinary fields, however, a more simple and rapid
detection method is required. Watanabe et al. [19] reported
on a monoclonal-based ELISA and an immunochromatographic
assay for monitoring monensin residues in chicken plasma
and cattle milk. In addition, several recent studies have
reported on a colloidal gold-based immunochromatographic
assay. Using this method, Shyu et al. [18] developed a
simple and reliable immunochromatographic assay for the
detection of ricin, and Putalun et al. [14] developed a one-
step immunochromatographic strip test for the detection of
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sennosides A and B.
In the present study, we produced a monoclonal antibody
against kanamycin, and developed a competitive direct
ELISA and immunochromatographic assay for the detection
of kanamycin in animal plasma and milk; an immuno-
chromatographic assay was developed using colloidal gold-
conjugated antibody as a rapid and simple screening method
for the detection of kanamycin in veterinary medicine.
Materials and Methods
Materials
Kanamycin sulfate, gentamicin sulfate, neomycin sulfate,
streptomycin sulfate, keyhole limpet hemocyanin (KLH), bovine
serum albumin (BSA), 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide hydrochloride (EDC), horseradish peroxidase
(HRP), goat anti-mouse IgG-horseradish peroxidase conjugate,
o-phenylenediamine dihydrochloride, hydrogen peroxide,
Freund’s complete adjuvant, Freund’s incomplete adjuvant,
polyoxyethylene-sorbitan monolaurate (Tween 20), and
colloidal gold particle were purchased from Sigma-Aldrich
(USA). Polyethylene glycol 1,500 (PEG 1,500), microtiter
plates, and microculture plates (96- and 24-well plates) were
obtained from Gibco BRL (USA). Monoclonal antibody
isotyping kit was obtained from Pierce (USA). BALB/c
mice and rabbits were purchased from Charles River
(Korea). High flow nitrocellulose membrane was obtained
from Millipore (USA).
Preparation of conjugates
Kanamycin was conjugated with KLH according to the
procedure described by Lewis et al. [12] using EDC.
Kanamycin-BSA and kanamycin-HRP conjugate were
prepared using the method of Haasnoot et al. [7].
Mouse immunization
The kanamycin-KLH conjugate was prepared by emulsifying
100 µg antigen conjugate in 100 µl PBS with equal volume
of Freund’s complete adjuvant using syringes. The emulsion
was injected intraperitoneally into BALB/c female mice (8-
10 weeks old). After 2 weeks, the mice were injected
intraperitoneally every 2 weeks with the emulsified mixture
of the immunogen and Freund’s incomplete adjuvant. A
final boosting of 100 µg antigen conjugate in 100 µl PBS,
without adjuvant, was performed to stimulate the blast cell
proliferation 4 days before fusion as described previously
[3]. Ten days after each injection, blood was collected from
the retrobulbar plexus of each mouse, and antibody titers
were determined by indirect ELISA using serially diluted
serum and goat anti-mouse IgG conjugated with peroxidase.
Preparation of monoclonal antibody
Hybridoma cell lines were produced by the fusion of
myeloma cells (Sp2/0) and spleen cells obtained from
immunized mice using PEG 1,500 as described previously
[8]. Twelve days after the fusion, competitive indirect
ELISA was performed to screen for antibody-producing
cells using culture supernatant. A stable hybridoma cell
producing antibody with the highest binding capacity and
sensitivity to kanamycin was selected, and cloned to 0.5
cells/well by limit dilution. The cultured hybridoma cells
(5 × 10
6 cell) were injected intraperitoneally into the mice,
and monoclonal antibody was prepared from the ascites
fluid of each mouse as described previously [8].
Isotype determination
The isotype class and subclass of the secreted antibody
were determined using a mouse monoclonal antibody
isotyping kit. Each well of the microtiter plates was coated
with 100 µl kanamycin-BSA conjugate (5 µg/ml) in 50 mM
sodium-bicarbonate buffer (pH 9.6) and incubated for 3 h at
37
oC. Unbound conjugate was removed from the plate with
washing solution (0.02% Tween 20 in PBS), and each well
was blocked with 200 µl blocking solution (1% skim milk in
50 mM sodium-bicarbonate buffer, pH 9.6) at 37
oC for 1 h.
After incubation with 50 µl cell culture supernatant, 50 µl
each of anti-mouse IgG1, IgG2a, IgG2b, IgG3, IgA, IgM,
kappa light chain, or lambda light chain produced in rabbit
was individually added to each well and incubated for 1 h at
37
oC. After washing, all wells were then further incubated
with 50 µl goat anti-rabbit IgG conjugated with peroxidase
for 1 h. After washing, 100 µl ABTS (2,2-azino-di[3-ethyl
benzthiazoline sulfonic acid]) substrate solution was added
to each well. Subsequently, the plates were incubated for
30 min at room temperature, and the color developed was
measured at 405 nm using an ELISA reader.
Cross-reactivity
To determine the specificity of the kanamycin antibody,
cross-reactivity of the antibody with other aminoglycosides
(gentamicin, neomycin, and streptomycin) was determined
by competitive indirect ELISA. The cross-reactivity at B/B0
value of 50% (CR50) was calculated as described previously
[10].
Competitive direct ELISA
Competitive direct ELISA was developed using monoclonal
antibody and kanamycin-HRP conjugate. Each well of the
microtiter plates was coated with 100 µl aliquots of
kanamycin antibody (diluted 1/2,000 in PBS) and incubated
for 3 h at 37
oC. Unbound antibody was removed from the
plate with the washing solution (0.02% Tween 20 in PBS),
and each well was blocked with 200 µl of blocking solution
(1% skim milk in PBS) at 37
oC for 1 h. Kanamycin
standards (50 µl each; 1 to 1,000 ng/ml) were added to each
well, and incubated with 50 µl diluted kanamycin-HRP
conjugate (diluted 1/2,000 in PBS) for 1 h at 37
oC. After
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conjugate with the washing solution, 100 µl of substrate
solution was added to each well, which was then incubated
for 20 min at 37
oC. Absorbance was measured at 490 nm
using an ELISA reader (Emax; Molecular Devices, USA).
To prepare the calibration curves of kanamycin in the
plasma and milk, kanamycin stock standard solutions (1,000
µg/ml) were prepared by dissolving kanamycin in the rabbit
plasma or bovine milk. The solutions were further diluted
with the plasma or milk to 0, 10, 20, 50, 100, 250, 500,
1,000, 2,500, 5,000, and 10,000 ng/ml, which were then
diluted 10-fold in PBS. The standard curves of kanamycin in
the plasma and milk were established by competitive direct
ELISA. The detection limits were determined as the mean
background levels plus three times the standard deviation.
Monitoring of blood concentration
Kanamycin was administered intramuscularly to rabbits at
20 mg/kg/day for 3 consecutive days. Blood samples were
collected from the ear vein of each rabbit 2, 4, 6, 8, 10, and
12 h after the last injection of kanamycin, and were
centrifuged (2,000 × g) for 10 min to obtain plasma. Plasma
samples were diluted 10-fold in PBS and subjected to
competitive direct ELISA to determine the kanamycin
concentration in the blood.
Immunochromatographic assay
Colloidal gold (40 nm in diameter) was conjugated with
anti-kanamycin monoclonal antibody as described previously
[18]. Briefly, 20 µg of purified monoclonal antibody was
added to 1 ml colloidal gold solution (pH 8.0). After
incubation at room temperature for 10 min, the conjugates
were blocked with 1% BSA solution for 30 min. The gold-
labeled antibody were supplied, ready to use, in 0.2 M Tris-
HCl buffer (pH 8.7) containing 1% Tirton X-100 at an
optical density of 10 at 540 nm. Since it was quite
concentrated, gold-labeled antibody was diluted 10-fold and
was measured at 540 nm using spectrophotometer.
One microliter (3 µg kanamycin-BSA) of kanamycin-BSA
(3 mg/ml) conjugate was applied to one end of the
nitrocellulose membrane strip (HF 135, 25 × 4.5 mm). After
drying, the lower edge of the test strip was dipped into the
well containing a mixture of 50 µl diluted sample (5-fold in
0.2 M Tris-HCl, pH 8.7, 1% Triton X-100) and 2 µl
colloidal gold-labeled monoclonal antibody. After the
mixture of sample and the gold-labeled antibody moved up
the membrane, the color intensities decreased with increasing
concentration of kanamycin in sample solutions was observed.
Results
Monoclonal antibody production
Monoclonal antibody against kanamycin was prepared as
described in Materials and Methods. After purification, the
isotype class and subclass of the antibody were determined
using a mouse monoclonal antibody isotyping kit. Based on
the results of the assay, the monoclonal antibody of kanamycin
was confirmed to be an IgG1, which has a kappa light chain
(Fig. 1).
Cross-reactivity
The purified monoclonal antibody did not show any cross-
reactivity with other aminoglycosides (gentamicin, neomycin,
and streptomycin) except kanamycin, indicating that the
monoclonal antibody was highly specific for kanamycin
(Table 1).
Competitive direct ELISA
To determine the detection limits of kanamycin in the
plasma and milk, standard curves of kanamycin in PBS,
rabbit plasma, and bovine milk were constructed by
competitive direct ELISA (Fig. 2). Detection limits of
kanamycin determined by the ELISA method are summarized
in Table 2. The detection limits, which were defined as the
mean background levels plus three times the standard
deviation, were 1.1 ng/ml in PBS, 1.4 ng/ml in plasma, and
1.0 ng/ml in milk, respectively (Table 2). Concentration of
intramuscularly injected kanamycin was successfully monitored
in rabbit plasma through competitive direct ELISA. The
Fig. 1. Determination of monoclonal antibody isotype. Rabbit
antisera specific for mouse IgG1, IgG2a, IgG2b, IgG3, IgA, IgM,
kappa light chain, and lambda light chain were added to each
well, and detected with goat anti-rabbit IgG conjugated wit h
peroxidase. The negative control included only pre-immune serum. 
Table 1. Cross-reactivity (CR50) of the monoclonal antibody of
kanamycin with aminoglycosides
Aminoglycosides CR50 (%)
Kanamycin 100
Gentamicin < 0.005
Neomycin < 0.005
Streptomycin < 0.005114 Yong Jin et al.
kanamycin concentration in blood sharply increased to
2,500 ng/ml after the intramuscular administration, for up to
2 h, and then rapidly decreased to less than 500 ng/ml 4 h
after withdrawal (Fig. 3).
Immunochromatographic assay
The gold-labeled monoclonal antibody of kanamycin did
not show any cross-reactivity with the other aminoglycosides
tested; as revealed by the immunochromatographic assay
(Fig. 4). Rabbit plasma, PBS, and bovine milk samples
spiked with kanamycin (0, 0.5, 1, 2, 4, 6, and 8 ng/ml) were
tested with the immunochromatographic assay (Fig. 5). The
color intensity gradually decreased with increasing concentration
of kanamycin, and disappeared completely at 6 or 8 ng/ml
of kanamycin in the samples. Therefore, as a result of the
immunochromatographic assay the detection limits were
estimated to be about 6-8 ng/ml of kanamycin in PBS,
plasma, and milk.
Plasma samples collected from rabbits 2, 4, 6, 8, 10, and
12 h after intramuscular injection of kanamycin (20 mg/kg/
day for 3 consecutive days) were subjected to immuno-
chromatographic assay (Fig. 6). No color development was
observed in all of the strips studied; this suggested that
plasma samples contained higher than 6 ng/ml of kanamycin.
Subsequent ELISA gave the accurate level of kanamycin
concentration (Fig. 6).
Discussion
We produced a monoclonal antibody that was highly
specific for kanamycin based on both an ELISA and an
immunochromatographic assay. The specificity of the
antibody can be explained by the differences in the molecular
structure of the aminoglycosides. All aminoglycosides
consist of two or more amino sugars joined by a glycosidic
linkage to a hexose nucleus, which is either streptose (found
in streptomycin) or 2-deoxystreptamin (characteristic of all
other aminoglycosides) [16]; the aminoglycoside families
are distinguished by the amino sugars attached to the
Fig. 2. Standard curve of kanamycin in PBS (○), rabbit plasma
(●), and bovine milk ( ▲) constructed through competitive
direct ELISA. B and B0 are the absorbance at 490 nm in the
presence or absence of free kanamycin. Each value shows the
mean (±SD) of B/B0 (n = 4).
Fig. 3. Depletion profile of kanamycin in rabbit plasma afte r
intramuscular administration of kanamycin. Kanamycin was
administered intramuscularly to rabbits at 20 mg/kg/day for 3
consecutive days. Blood samples were collected from the ea r
vein of each rabbit 2, 4, 6, 8, 10, and 12 h after the last injectio n
of kanamycin. Plasma samples were diluted 10-fold in PBS an d
subjected to the competitive direct ELISA. Each value shows the
mean (±SD) of kanamycin concentration (n = 4).
Table 2. Detection limits of kanamycin determined by competitive direct ELISA
Mean background level* (ng/ml) Standard deviation (ng/ml) Detection limits** (ng/ml)
PBS 0.62 0.15 1.07
Plasma 0.71 0.23 1.4
Milk 0.71 0.11 1.04
*Mean background levels were obtained from the standard curves of kanamycin in PBS, rabbit plasma, and bovine milk constructed  by competitive
direct ELISA.
**Detection limits:
 the mean background levels plus three times standard deviation (Bo+3 SD).Kanamycin detection using immunoassays 115
nucleus. In either kanamycin or gentamicin, two amino
sugars are attached to 2-deoxystreptamin, whereas neomycin
has three amino sugars attached. In addition, kanamycin
reacts with the antibody specific to its structure, because the
molecular structure of the attached sugars is quite different
from those of neomycin, gentamicin, and streptomycin [7].
These identified structural differences enable each antibody
to recognize its own specific antigen.
After intramuscular administration, the kanamycin
concentration in blood sharply increased for up to 2 h, and
then rapidly decreased 4 h after withdrawal. When
aminoglycosides are administered into the body cavity,
which contain serosal surfaces, extremely rapid and
complete absorption takes place; whereas slow absorption is
observed when it is administered orally or rectally [17]. In
addition, Isoherranen and Soback [9] reported that
aminoglycosides bind readily to tissue proteins and
macromolecules with ionic bonds; while such binding is less
evident with plasma proteins. They also showed that
aminoglycoside accumulation in the renal proximal tubules
was several-fold higher than in the plasma or other tissues,
and that the half-life of aminoglycosides was 2-3, and 30-
700 h, in plasma and tissues, respectively. Therefore, due to
the longer and more variable half-life of aminoglycosides in
the tissues compared to plasma, we plan a future study to
determine the time-dependent concentration of kanamycin
in milk, blood, and tissues after administration of kanamycin
to cows with mastitis. The ELISA method developed in this
study could be applied to determine the aminoglycoside
concentration in the plasma of live animals.
In veterinary medicine, a simple and rapid detection
method for aminoglycoside levels is required. Recently,
several studies have focused on colloidal gold-based
immunochromatographic assays [14,18]. The application of
immunogold detection has several advantages. First, the
nanoparticles of colloidal gold show better mobility than
other materials in a porous nitrocellulose membrane.
Second, the colloidal gold particles are less susceptible to
aggregation during the preparation. Finally, a gold-labeled
antibody improves assay sensitivity [18]. In the present
study, a compromise was made between the sensitivity and
the non-specific binding of antigen-antibody reactions in the
immunochromatographic assay. On the basis of the findings,
that the pH and the composition of the developing solution
were important for better resolution, we optimized the assay
conditions for better sensitivity without any cross-reactivity
or non-specific binding.
In conclusion, due to its rapid and simple application, the
colloidal gold-based immunochromatographic assay can be
applied to the detection of kanamycin in veterinary
medicine. For greater accuracy, however, detection should
be supported by a more sensitive laboratory method such as
Fig. 4. Cross-reactivity of the monoclonal antibody of kanamyci n
with aminoglycosides in immunochromatographic assay. Three
microgram of kanamycin-BSA, gentamicin-BSA, neomycin-BSA,
or streptomycin-BSA conjugate was applied to each strip of  a
nitrocellulose membrane. After the gold-labeled antibody move d
up the membrane, the intensity of the red color band on eac h
membrane strip was observed.
Fig. 5. Immunochromatographic assay for the detection of kanamycin. A series of dilutions (0, 0.5, 1, 2, 4, 6, and 8 ng/ml) o f
kanamycin were prepared in PBS (A), rabbit plasma (B), and bovine milk (C).116 Yong Jin et al.
the competitive direct ELISA method. The assays developed
in this study could complement each other and provide a
useful tool for veterinary medicine. Moreover, instead of
slaughtering animals, to obtain test samples, the methods
developed in the present study can be applied to determine
kanamycin concentration in the plasma of live animals.
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